| Name | Walgreens #6863 |
|---|---|
| Organization Name | Walgreen Co |
| Location | 335 W Appleway Ave, Coeur D Alene, Idaho 83814 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Phone | (208) 765-1254 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
Armaron Bio, a Melbourne-based drug development company focused on heart failure and other diseases, is pleased to announce that it has begun its Phase II clinical trial for NP202, its novel lead candidate drug for heart failure.
In the third post in a series by Marie Stopes International published on the Bill & Melinda Gates Foundation's "Impatient Optimists" blog, Mukanga Sindazi, the outreach team leader with Marie Stopes in Zambia, discusses his work traveling through the rural Central Province to educate women and men about family planning and provide modern contraceptives.
KemPharm, Inc. today announced the nomination of its second pipeline candidate, KP201, based on its proprietary ligand activated therapy (LAT) platform. KP201 is a new chemical entity (NCE) for the treatment of pain with the possibility of reduced abuse potential. KP201 joins lead candidate KP106, which is a novel prodrug candidate in development for ADHD.
Luminex Corporation, the worldwide leader in multiplexed solutions, and High Throughput Genomics, Inc. (HTG), provider of the quantitative Nuclease Protection Assay (qNPA™), today launched a new custom gene expression product, the qBead Gene Expression Assay (qBead Assay). The companies co-developed the product and have signed an exclusive distribution agreement in which Luminex will begin offering it to the research community.
› Verified 2 days ago
| NPI Number | 1962417089 |
| Organization Name | WALGREEN CO |
| Doing Business As | WALGREENS #06863 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | 335 W Appleway Ave, Coeur D Alene, ID 83814 |
| Phone Number | 208-765-1254 |
News Archive
Armaron Bio, a Melbourne-based drug development company focused on heart failure and other diseases, is pleased to announce that it has begun its Phase II clinical trial for NP202, its novel lead candidate drug for heart failure.
In the third post in a series by Marie Stopes International published on the Bill & Melinda Gates Foundation's "Impatient Optimists" blog, Mukanga Sindazi, the outreach team leader with Marie Stopes in Zambia, discusses his work traveling through the rural Central Province to educate women and men about family planning and provide modern contraceptives.
KemPharm, Inc. today announced the nomination of its second pipeline candidate, KP201, based on its proprietary ligand activated therapy (LAT) platform. KP201 is a new chemical entity (NCE) for the treatment of pain with the possibility of reduced abuse potential. KP201 joins lead candidate KP106, which is a novel prodrug candidate in development for ADHD.
Luminex Corporation, the worldwide leader in multiplexed solutions, and High Throughput Genomics, Inc. (HTG), provider of the quantitative Nuclease Protection Assay (qNPA™), today launched a new custom gene expression product, the qBead Gene Expression Assay (qBead Assay). The companies co-developed the product and have signed an exclusive distribution agreement in which Luminex will begin offering it to the research community.
› Verified 2 days ago
News Archive
Armaron Bio, a Melbourne-based drug development company focused on heart failure and other diseases, is pleased to announce that it has begun its Phase II clinical trial for NP202, its novel lead candidate drug for heart failure.
In the third post in a series by Marie Stopes International published on the Bill & Melinda Gates Foundation's "Impatient Optimists" blog, Mukanga Sindazi, the outreach team leader with Marie Stopes in Zambia, discusses his work traveling through the rural Central Province to educate women and men about family planning and provide modern contraceptives.
KemPharm, Inc. today announced the nomination of its second pipeline candidate, KP201, based on its proprietary ligand activated therapy (LAT) platform. KP201 is a new chemical entity (NCE) for the treatment of pain with the possibility of reduced abuse potential. KP201 joins lead candidate KP106, which is a novel prodrug candidate in development for ADHD.
Luminex Corporation, the worldwide leader in multiplexed solutions, and High Throughput Genomics, Inc. (HTG), provider of the quantitative Nuclease Protection Assay (qNPA™), today launched a new custom gene expression product, the qBead Gene Expression Assay (qBead Assay). The companies co-developed the product and have signed an exclusive distribution agreement in which Luminex will begin offering it to the research community.
› Verified 2 days ago
Apria Healthcare Llc Type: Durable Medical Equipment & Medical Supplies Supplier Location: 2944n Government Way, Coeur D Alene, Idaho 83815 Phone: (208) 667-1195 | |
Interlake Pharmacy Inc Type: Durable Medical Equipment & Medical Supplies Supplier Location: 700 W Ironwood Dr, Coeur D Alene, Idaho 83814 Phone: (208) 664-6664 | |
Heritage Health Type: Pharmacy Location: 1090 W Park Pl, Coeur D Alene, Idaho 83814 Phone: (208) 215-2005 | |
Lincare Inc Type: Durable Medical Equipment & Medical Supplies Supplier Location: 3786 N Huetter Rd, Coeur D Alene, Idaho 83814 Phone: (208) 765-3422 | |
Rite Aid Pharmacy 05420 Type: Medicare Supplier Location: 208 W Ironwood Dr, Coeur D Alene, Idaho 83814 Phone: (208) 664-3185 |